Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Myocardial Ischemia: full-pipeline trial registry
4 of 31 indexed Myocardial Ischemia trials are currently recruiting.
Corpus placement: #495 of 28,707 conditions by registered trial count.
31 US clinical trials · 4 currently recruiting · #495 of 28,707 conditions by registered trial count
Myocardial Ischemia: 31 US clinical trials tracked, 4 recruiting.
Myocardial Ischemia is the subject of 31 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 3 of these trials.
Enrollment posture brief
Registry condition myocardial-ischemia
OPEN 4 | RECR 13% | LATE 7 | EARLY 6 | RANK #495 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Melanoma (Skin) (13% recruiting · 54 trials)
Myocardial Ischemia lists 4 open slots (13% of 31 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Myocardial Ischemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Myocardial Ischemia is recruiting below its size-band peers.
4 of 31 indexed trials (12.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Myocardial Ischemia trials is spread across many organizations.
NYU Langone Health accounts for 3 of 31 trials (9.7%). 26 distinct sponsors appear on at least one study for this condition label.
-
Typical Myocardial Ischemia enrolment sits around 300 participants.
Median target enrolment is 300 among the 30 trials that report a genuine target (sentinel values excluded). 10 of those (33.3%) plan for fewer than 100 participants.
-
Myocardial Ischemia research is mostly interventional.
27 interventional and 4 observational studies make up this index (87.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
31 total, page 1 of 1
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
NCT06271577
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Fundación EPIC
NCT07286578
Bright Light Exposure in Surgical Patients
University of Colorado, Denver
NCT03822949
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
University of Virginia
NCT05762952
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
VA Office of Research and Development
NCT02694185
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
NYU Langone Health
NCT03537586
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00809965
SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
Sanofi
NCT00043784
ECG Methods for the Prompt Identification of Coronary Events
University of Pittsburgh
NCT04237688
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
NYU Langone Health
NCT01471522
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)
Abbott Medical Devices
NCT01120379
Clinical Decision Support for Medication Management and Adherence
Duke University
NCT00979225
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
Medicure
NCT00402506
Stress CMR Perfusion Imaging in the United States (SPINS) Study
Society for Cardiovascular Magnetic Resonance
NCT03192891
An Observational Study of Cholesterol in Coronary Arteries
Infraredx
NCT00831116
ISCHEMIA-Chronic Kidney Disease Trial
NYU Langone Health
NCT01985360
ACT34-CMI -- Adult Autologous CD34+ Cells
Lisata Therapeutics
NCT00300053
Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
Avant Immunotherapeutics
NCT00082121
Collaborative Cardiac Care Project
US Department of Veterans Affairs
NCT00105664
Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
Mayo Clinic
NCT00170027
Sapphire 3 CTO Study
OrbusNeich
NCT06358508
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Marc Sakwa, MD
NCT01681095
AngioSculpt® Coronary Bifurcation Study
AngioScore
NCT00686647
Electromechanical Mapping to Evaluate Heart Muscle
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001895
A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement
University of Oklahoma
NCT00756236
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
University of California, San Francisco
NCT01877941
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
Cedars-Sinai Medical Center
NCT00600106
Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients With Coronary Artery Disease
National Heart, Lung, and Blood Institute (NHLBI)
NCT00014040
Precision of the Magnetocardiographer for Data Aquision and Analysis.
Mayo Clinic
NCT00170014
Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Kent Hospital, Rhode Island
NCT02360397
The Effect of Exercise Training on Mental Stress-Induced Silent Ischemia
US Department of Veterans Affairs
NCT00018252
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 6 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Myocardial Ischemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Myocardial Ischemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Myocardial Ischemia page
31 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Myocardial Ischemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NYU Langone Health sponsors the most Myocardial Ischemia trials on record, review their full trial history before evaluating a specific study. See NYU Langone Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myocardial Ischemia condition card totals 31 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.